IMPROVING ONCOLOGY RESEARCH WITH BUILT-IN KRAS ASSAY COMPANIES AND RAS ASSAYS

from the fast evolving industry of oncology research, exact and economical mutation screening is essential for creating focused therapies. The KRAS companies Platform plays a pivotal job With this landscape by providing detailed alternatives for KRAS mutation profiling and Investigation. KRAS mutations, located in around ninety five% of RAS-relevan